(19)
(11) EP 1 643 973 A1

(12)

(43) Date of publication:
12.04.2006 Bulletin 2006/15

(21) Application number: 04740921.4

(22) Date of filing: 08.07.2004
(51) International Patent Classification (IPC): 
A61K 9/14(1974.07)
(86) International application number:
PCT/EP2004/007666
(87) International publication number:
WO 2005/004845 (20.01.2005 Gazette 2005/03)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
HR LT LV

(30) Priority: 11.07.2003 GB 0316341
23.09.2003 US 505415 P

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 0NN (GB)

(72) Inventors:
  • MONTEITH, Michael, John, GlaxoSmithKline
    Stevenage Hertfordshire SG1 2NY (GB)
  • THOMAS, Marian, GlaxoSmithKline
    Ware Hertfordshire SG12 0DP (GB)

(74) Representative: Florence, Julia Anne et al
GlaxoSmithKline Corporate Intellectual Property CN925.1 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) PHARMACEUTICAL FORMULATIONS COMPRISING MAGNESIUM STEARATE